AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Health systems are moving from AI experimentation to proof-and-scale economics
Philips is putting a sharper business lens on healthcare AI, arguing that vendors and buyers need to prove impact before scaling it. The message reflects a maturing market where evidence, not enthusiasm, is becoming the main currency.
Philips pushes for proof, scale, and sharing as healthcare AI enters its commercialization phase
Philips is emphasizing evidence generation and replication as the healthcare AI market matures. The message is that vendors will increasingly be judged on demonstrated outcomes, not just technical novelty.
Philips Wins FDA Clearance for Rembra Scanning Platform
Philips has received FDA clearance for its Rembra scanning platform, adding another AI-enabled imaging system to the market. The clearance matters not only as a product milestone, but also as evidence that regulators are continuing to clear complex imaging software with increasing confidence.
Philips Wins FDA Clearance for Verida, a Detector-Based Spectral CT Platform
Philips has received FDA clearance for Verida, its detector-based spectral CT platform powered by AI. The clearance adds momentum to a category where spectral imaging is becoming a practical product strategy, not just a technical differentiator.
Philips Wins FDA Nod for a New AI-Powered Spectral CT Platform
Philips has secured FDA clearance for Verida, its detector-based spectral CT system that pairs advanced imaging hardware with AI-driven reconstruction and workflow support. The clearance adds momentum to a fast-developing imaging category where vendors are increasingly bundling AI into the scanner itself rather than treating it as a separate add-on.
Philips Wins FDA Clearance for Verida Spectral CT, Sharpening the Imaging AI Race
Philips secured FDA clearance for its Verida spectral CT system, adding another high-profile imaging platform to the U.S. market. The approval underscores how major vendors are pairing hardware advances with AI-enabled analysis to defend and expand their imaging franchises.
Philips Wins FDA Clearance for AI-Enabled CT, Signaling Imaging AI’s Hardware Shift
Philips has secured FDA clearance for an AI-enabled CT system, another sign that imaging vendors are increasingly competing on software intelligence as much as detector performance. The clearance underscores how AI is becoming part of the product definition rather than a bolt-on feature.
Philips Wins FDA Clearance for AI-Powered Spectral CT, Raising the Imaging Stakes
Philips’ FDA nod for AI-powered detector-based spectral CT adds momentum to the imaging market’s shift toward faster, more data-rich workflows. The clearance is notable not just for the product itself, but for what it signals about how imaging vendors are bundling AI into next-generation hardware.
Philips’ FDA Nod for Spectral CT Shows AI Is Becoming a Hardware Differentiator
Philips has won FDA clearance for AI-powered, detector-based spectral CT technology. The approval reinforces a bigger trend in medical imaging: AI is increasingly being bundled into core device performance rather than sold as a standalone add-on.
Philips Wins FDA Clearance for Verida Spectral CT, Signaling Momentum for Advanced Imaging AI
Philips has received FDA clearance for its Verida spectral CT system, adding to the commercial momentum behind advanced imaging platforms. The clearance is notable not just as a product milestone, but as evidence that imaging companies are pairing hardware innovation with AI-enabled clinical differentiation.
Philips Wins FDA Clearance for AI Heart Valve Repair Solution
Philips has won FDA 510(k) clearance for an AI-enabled heart valve repair solution, adding to the company’s footprint in image-guided structural heart care. The clearance points to a growing market for software that helps clinicians plan and execute complex procedures with more precision.
FDA recall of Philips Azurion systems puts imaging workflow safety back in focus
The FDA has issued a Class 2 recall for Philips’ Azurion interventional radiology systems, a reminder that software-enabled imaging platforms carry operational risks even when problems stop short of the most severe recall tier. The episode highlights how modern imaging safety increasingly depends on system behavior, workflow design, and postmarket responsiveness rather than hardware alone.
Philips’ FDA Clearance Shows AI Is Becoming Native to Interventional Cardiology
Philips has won FDA clearance for AI-enabled guidance software in heart valve repair, underscoring a shift from image interpretation AI to procedure-embedded intelligence. The bigger story is that AI is moving into the cath lab and hybrid OR as a live navigation layer rather than a retrospective analytic tool.
FDA clearance for Philips valve-repair guidance shows where imaging AI can win first
Philips says the FDA has cleared an AI solution that provides real-time guidance during complex minimally invasive heart valve repair. The approval highlights a commercially important direction for medical AI: narrow, procedural tools that augment specialist workflows at the point of care.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.